In Vivo Fluorometric Assessment of Cyclosporine on Mitochondrial Function During Myocardial Ischemia and Reperfusion

Annals of Thoracic Surgery

Volumn 89, Issue 5, 2010, Pages 1532-1537

  Matsubara, Muneaki ^a   Ranji, Mahsa ^b   Leshnower, Bradley G ^a   Noma, Mio ^a   Ratcliffe, Sarah J ^a   Chance, Britton ^a   Gorman, Robert C ^a   Gorman III, Joseph H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b University of Wisconsin Milwaukee   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; FLAVINE ADENINE NUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; CYCLOSPORIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN INFARCTION SIZE; CELL STRUCTURE; FLUOROMETRY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPOTHESIS; HYPOXIA; IN VIVO STUDY; MALE; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; SPECTROSCOPY; STAINING; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART MITOCHONDRION; IMMUNOHISTOCHEMISTRY; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; RABBIT; RANDOMIZATION; REFERENCE VALUE; REPERFUSION INJURY; RISK ASSESSMENT; SPECTROFLUOROMETRY;

ANIMALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MITOCHONDRIA, HEART; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY; RABBITS; RANDOM ALLOCATION; REFERENCE VALUES; RISK ASSESSMENT; SPECTROMETRY, FLUORESCENCE;

EID: 77953056138     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2010.01.065     Document Type: Article

References (22)

1. Weinbrenner C., Liu G.S., Downey J.M., and Cohen M.V. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res 38 (1998) 678-684
2. Griffiths E.J., and Halestrap A.P. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 25 (1993) 1461-1469
3. Hausenloy D.J., Maddock H.L., Baxter G.F., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc Res 55 (2002) 534-543
4. Argaud L., Gateau-Roesch O., Muntean D., et al. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 38 (2005) 367-374
5. Leshnower B.G., Kanemoto S., Matsubara M., et al. Cyclosporine preserves mitochondrial morphology after myocardial ischemia/reperfusion independent of calcineurin inhibition. Ann Thor Surg 86 (2008) 1286-1292
6. Piot C., Criosille P., Staat P., Thibault H., et al. Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med 359 (2008) 473-481
7. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., and Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94 (1994) 1621-1628
8. Bromme H.J., and Holtz J. Apoptosis in the heart: when and why?. Mol Cell Biochem 164 (1996) 261-275
9. Niemann C.U., Saeed M., Akabari H., et al. Close association between the reduction in myocardial energy metabolism and infarct size: dose-response assessment of cyclosporine. J Pharmacol Exp Ther 302 (2002) 1123-1128
10. Hassinen I., and Chance B. Oxidation-reduction properties of the mitochondrial flavoprotein chain. Biochem Biophys Res Commun 31 (1968) 895-900
11. Chance B., Schoener B., Oshino R., Itshak F., and Nakase Y. Oxidation-reduction ratio studies of mitochondria in freeze-trapped samples. NADH and flavoprotein fluorescence signals. J Biol Chem 254 (1979) 4764-4771
12. Chance B., Oshino N., Sugano T., and Mayevsky A. Basic principles of tissue oxygen determination from mitochondrial signals. Adv Exp Med Biol 37 (1973) 277-282
13. Ranji M., Matsubara M., Leshnower B.G., et al. Quantifying acute myocardial injury using ratiometric fluorometry. IEEE Trans Biomed Eng 56 (2009) 1556-1563
14. Ranji M., Jaggard D.L., and Chance B. Observation of mitochondrial morphology and biochemistry changes undergoing apoptosis by angularly resolved light scattering and cryoimaging. Proc SPIE 6087 (2006) 60780K1-9
15. Laird N.M., and Ware J.H. Random effects models for longitudinal data. Biometrics 38 (1982) 963-974 4
16. Kroemer G., Dallaporta B., and Resche-Rignon M. The mitochondrial death/life regulator in apoptosis and necrosis. Annu Rev Physiol 60 (1998) 619-642
17. Duchen M.R., McGuiness O., Brown L.A., and Crompton M. On the involvement of a cyclosporin: A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc Res 27 (1993) 1790-1794
18. Halestrap A.P. Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34 (2006) 232-237
19. Griffiths E.J., and Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia but open upon reperfusion. Biochem J 307 (1995) 93-99
20. Zoratti M., and Szabò I. The mitochondrial permeability transition. Biochim Biophys Acta 1241 (1995) 139-176
21. Narula J., Haider N., Virmani R., et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335 (1996) 1182-1189
22. Narula J., Elmo R.A., et al. Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7 (2001) 1347-1352